A detailed history of Keudell transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Keudell holds 8,864 shares of GILD stock, worth $780,741. This represents 0.18% of its overall portfolio holdings.

Number of Shares
8,864
Previous 8,852 0.14%
Holding current value
$780,741
Previous $648,000 6.17%
% of portfolio
0.18%
Previous 0.2%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$63.15 - $72.88 $757 - $874
12 Added 0.14%
8,864 $608,000
Q1 2024

May 07, 2024

BUY
$71.58 - $87.29 $128,414 - $156,598
1,794 Added 25.42%
8,852 $648,000
Q4 2023

Feb 14, 2024

SELL
$73.27 - $83.09 $48,284 - $54,756
-659 Reduced 8.54%
7,058 $571,000
Q3 2023

Oct 18, 2023

BUY
$73.94 - $80.67 $49,096 - $53,564
664 Added 9.41%
7,717 $578,000
Q2 2023

Jul 20, 2023

SELL
$76.01 - $86.7 $103,297 - $117,825
-1,359 Reduced 16.16%
7,053 $543,000
Q1 2023

Apr 18, 2023

SELL
$77.31 - $88.08 $280,016 - $319,025
-3,622 Reduced 30.1%
8,412 $697,000
Q4 2022

Jan 20, 2023

SELL
$62.32 - $89.47 $98,278 - $141,094
-1,577 Reduced 11.59%
12,034 $0
Q3 2022

Oct 12, 2022

BUY
$59.54 - $68.01 $11,014 - $12,581
185 Added 1.38%
13,611 $840,000
Q2 2022

Jul 18, 2022

BUY
$57.72 - $65.01 $89,985 - $101,350
1,559 Added 13.14%
13,426 $830,000
Q1 2022

Apr 18, 2022

BUY
$57.92 - $72.58 $141,035 - $176,732
2,435 Added 25.82%
11,867 $705,000
Q4 2021

Feb 08, 2022

SELL
$64.88 - $73.64 $84,019 - $95,363
-1,295 Reduced 12.07%
9,432 $685,000
Q3 2021

Oct 20, 2021

BUY
$67.69 - $73.03 $31,002 - $33,447
458 Added 4.46%
10,727 $749,000
Q2 2021

Jul 13, 2021

BUY
$63.47 - $69.35 $13,963 - $15,256
220 Added 2.19%
10,269 $707,000
Q1 2021

Apr 13, 2021

BUY
$60.0 - $68.46 $60,420 - $68,939
1,007 Added 11.14%
10,049 $649,000
Q4 2020

Feb 12, 2021

BUY
$56.65 - $64.55 $78,177 - $89,079
1,380 Added 18.01%
9,042 $527,000
Q3 2020

Oct 20, 2020

BUY
$62.1 - $78.08 $193,317 - $243,063
3,113 Added 68.43%
7,662 $484,000
Q2 2020

Jul 14, 2020

SELL
$72.34 - $84.0 $304,045 - $353,052
-4,203 Reduced 48.02%
4,549 $350,000
Q1 2020

Apr 20, 2020

BUY
$62.63 - $80.22 $7,515 - $9,626
120 Added 1.39%
8,752 $654,000
Q4 2019

Jan 29, 2020

BUY
$61.62 - $67.78 $54,718 - $60,188
888 Added 11.47%
8,632 $561,000
Q3 2019

Nov 13, 2019

BUY
$62.51 - $69.0 $135,771 - $149,868
2,172 Added 38.98%
7,744 $491,000
Q2 2019

Aug 23, 2019

BUY
$61.87 - $69.38 $344,739 - $386,585
5,572 New
5,572 $356,000
Q2 2019

Aug 21, 2019

SELL
$61.87 - $69.38 $190,807 - $213,967
-3,084 Closed
0 $0
Q1 2019

Aug 21, 2019

BUY
$62.53 - $70.05 $192,842 - $216,034
3,084 New
3,084 $200,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Keudell Portfolio

Follow Keudell and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keudell, based on Form 13F filings with the SEC.

News

Stay updated on Keudell with notifications on news.